Login / Signup

Inhibition of branched-chain alpha-keto acid dehydrogenase kinase augments the sensitivity of ovarian and breast cancer cells to paclitaxel.

Suad Lateef IbrahimMohammed Najim AbedGehad MohamedJoshua C PriceMarwan Ibrahim AbdullahAlan Richardson
Published in: British journal of cancer (2022)
BCKDK is an attractive target to augment the sensitivity of cancer cells to paclitaxel.
Keyphrases
  • breast cancer cells
  • tyrosine kinase
  • protein kinase
  • chemotherapy induced